Fresenius reported €2.68B in Gross Profit on Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Akzo Nobel AKZA:NA 1.03B 52M
Alcon AG ALC:SW 1.19B 22.42M
AstraZeneca AZN:LN 8.87B 244M
BASF BAS:GR 5.84B 162M
Bayer BAYN:GR 7.14B 2.32B
Davita Healthcare Partners DVA:US $ 909.97M 110.94M
Essilor EI:FP 7.61B 808M
Fresenius FRE:GR € 2678M 120M
Fresenius Medical Care FME:GR € 1346M 87.9M
Getinge GETIB:SS 3.15B 96M
Givaudan GIVN:VX 1.46B 84M
GlaxoSmithKline GSK:LN 4.79B 1.34B
Hikma Pharmaceutical HIK:LN 623M 62M
Lonza Group LONN:SW 1.2B 129M
Merck MRK:GR € 3459M 248M
Novartis NOVN:VX 9.34B 277M
Philips PHIA:NA € 1732M 221M